Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information
12 Months Ended
Nov. 30, 2017
Document and Entity Information [Abstract]  
Entity Registrant Name Intellipharmaceutics International Inc.
Trading Symbol ipci
Document Type 20-F
Current Fiscal Year End Date --11-30
Entity Common Stock, Shares Outstanding 34,704,515
Amendment Flag false
Entity Central Index Key 0001474835
Entity Current Reporting Status Yes
Entity Voluntary Filers No
Entity Filer Category Non-accelerated Filer
Entity Well-known Seasoned Issuer No
Document Period End Date Nov. 30, 2017
Document Fiscal Year Focus 2017
Document Fiscal Period Focus FY